MAL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.44249065417534E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62736490949555E-12 |
Normal-vs-Stage2 |
1.68698388591793E-12 |
Normal-vs-Stage3 |
9.99200722162641E-16 |
Normal-vs-Stage4 |
1.6251444634463E-12 |
Stage1-vs-Stage2 |
2.132600E-01 |
Stage1-vs-Stage3 |
1.537350E-01 |
Stage1-vs-Stage4 |
6.114200E-02 |
Stage2-vs-Stage3 |
7.386500E-02 |
Stage2-vs-Stage4 |
4.445900E-02 |
Stage3-vs-Stage4 |
5.748800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.55431223447522E-15 |
Normal-vs-AfricanAmerican |
1.66111568944416E-12 |
Normal-vs-Asian |
8.819300E-03 |
Caucasian-vs-AfricanAmerican |
9.893800E-02 |
Caucasian-vs-Asian |
3.520200E-01 |
AfricanAmerican-vs-Asian |
5.334600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62825308791525E-12 |
Normal-vs-Female |
1.62536650805123E-12 |
Male-vs-Female |
3.096100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.82376336255174E-12 |
Normal-vs-Age(41-60Yrs) |
1.62714286489063E-12 |
Normal-vs-Age(61-80Yrs) |
1.62669877568078E-12 |
Normal-vs-Age(81-100Yrs) |
1.62458935193399E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.100200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.793800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.322100E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.327800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.362040E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.972160E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.0547118733939E-14 |
Normal-vs-Grade 2 |
1.63191682389652E-12 |
Normal-vs-Grade 3 |
1.62536650805123E-12 |
Normal-vs-Grade 4 |
5.55111512312578E-16 |
Grade 1-vs-Grade 2 |
3.258000E-01 |
Grade 1-vs-Grade 3 |
7.210400E-01 |
Grade 1-vs-Grade 4 |
9.477400E-01 |
Grade 2-vs-Grade 3 |
6.203500E-03 |
Grade 2-vs-Grade 4 |
4.435500E-03 |
Grade 3-vs-Grade 4 |
5.644600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.33066907387547E-16 |
Normal-vs-ccB subtype |
1.94289029309402E-14 |
ccA subtype-vs-ccB subtype |
2.14899999995133E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.44249065417534E-15 |
Normal-vs-N1 |
9.36669630746678E-11 |
N0-vs-N1 |
1.313960E-01 |
|
|